Launching one of the largest and most efficient cannabis facilities on the planet.
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry.
AgraFlora owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Services Canada Inc. and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company is also retrofitting a 51,500-squarefoot good manufacturing practice (“GMP”) edibles manufacturing facility in Winnipeg, Manitoba.
A Focus on Execution
AgraFlora is focused on providing premium quality cannabis to consumers through a stable of product lines. The cannabis market has many players and differentiation is critical:
To date, the Company has deployed over $115-million in associated PPE expenditures related to its cultivation, manufacturing and distribution assets. These accretive PPE expenditures have positioned Agraflora to capture defendable market share within Canada’s growing domestic cannabis arena.
AgraFlora has assembled a portfolio of trusted consumer brands tactical situated at the nexus of the adult use and health and wellness markets. The Company has leveraged strategic relationships, proprietary investments and exclusive partnerships with pre-eminent international cannabis cultivators and formulator peer groups to develop a portfolio of best-in-class products and brands to be marketed and distributed throughout its global footprint.
Off-take & Commercial Rights Agreement
Five year, 100,000,000 gram off-take agreement.
Commercial Rights Agreement
Commercial rights for cannabis processing/finishing at ICC’s European-GMP (good manufacturing practice) certified facilities.
Unbridled access to its European distribution network composed of 80,000 retail outlets and pharmacies, augmented by various value-added services, including:
- Strategic procurement;
- Product registration;
- Regulatory representations.
Five year, 25,000,000 gram off-take agreement.
European Distribution Agreement
- Among the top 5 players in the German distribution market
- Core focus on efficient distribution, fast execution & product development
- Lean, aggressive distribution as basis for upscaling & European expansion strategy
PERMITS & LICENCES
- Permit for Narcotic Drug Handling (§3 BtmG)
- Wholesale license for distribution of medicinal products (§ 52a AMG), including imports/exports
- Certificate of Good Distribution Practice (GDP)
Global Distribution Agreement
CBD Group Asia Ltd., controls a distribution agreement for CBD and hemp-derived beauty and wellness products for the territories of People’s Republic of China and Hong Kong special administrative region. The distribution agreement extends to Agraflora’s diverse portfolio of CBD-infused and/or hemp-oil-derived CPG personal care products, for which CBD Group Asia will have an exclusive for sales in China, including but not limited to:
- CBD-infused cosmetics;
- Hemp body soaps;
- Hemp-derived lotions and skin serums;
- CBD-infused sunscreen.
AgraFlora Organics Submits Response to Request for More Information from Health Canada and Moves Towards Processing Licence its Winnipeg Edibles Manufacturing Facility
Vancouver British Columbia / October 2, 2020 – AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce that the Company has submitted a formal response to Health Canada’s first Request for More Information (“RMI”) regarding the Standard Processing License (the “Manufacturing License”) application for AgraFlora’s 51,000-Square-foot fully-automated edibles manufacturing facility in Winnipeg, Manitoba (the “Edibles Facility”).
AgraFlora’s Subsidiary Farmako Secures Additional Supply of EU-GMP Cannabis via Definitive Supply Agreement with ZenPharm Limited
Vancouver British Columbia / September 15, 2020 – AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce that its wholly owned subsidiary Farmako GmbH (“Farmako”) has executed the binding supply agreement (the “Supply Agreement”) with ZenPharm Ltd (“ZenPharm”), a subsidiary of Zenabis Global Inc. (TSX: ZENA) (“Zenabis”).
AGRAFLORA ORGANICS COMMENCES RESEARCH AND DEVELOPMENT TRIALS AT WINNIPEG BASED EDIBLES MANUFACTURING FACILITY
Vancouver British Columbia / August 27, 2020 – AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce that the Company has received a necessary CRA tax license and is now creating test cannabis edibles products through its Health Canada licensed Research and Development Lab (“R&D Lab”) within its 51,000-Square-foot fully-automated edibles manufacturing facility in Winnipeg, Manitoba (the “Edibles Facility”).